World's Best Scientists 2026 revealed!
Andrew A. Nierenberg

Andrew A. Nierenberg

D-Index & Metrics

Medicine

D-Index
130
Citations
73949
World Ranking
2464
National Ranking
1393

Overview

Andrew A. Nierenberg is affiliated with Harvard University in the United States. Their research primarily spans topics related to mental health and psychiatry, with a focus on areas such as tryptophan and brain disorders, treatment of major depression, schizophrenia research and treatment, and stress responses involving cortisol. Their work covers aspects of health, psychology, and well-being as well.

Their recent published papers include:

  • "The United States index of socioeconomic deprivation for individuals (USiDep)" (2022) in Personalized Medicine in Psychiatry
  • "Lessons learned: Building a coalition to advance equity in cancer and mental health care" (2021) in Psycho-Oncology
  • "Early antibiotic exposure and risk of psychiatric and neurocognitive outcomes: systematic review and meta-analysis" (2024) in The British Journal of Psychiatry
  • "Real-World Impact of Pharmacogenomic Testing on Medication Use and Healthcare Resource Utilization in Patients With Major Depressive Disorder" (2025) in Journal of Clinical Psychopharmacology
  • "How Do We Actually Make a Diagnosis? Lessons Learned From the Bipolar Action Network" (2024) in Psychiatric Annals

Their frequent coauthors include Michael Berk, Wolfgang Marx, David Castle, John F. Cryan, and Eugene Athan, each having collaborated on multiple publications.

Key venues for their work are:

  • Psychiatric Annals (18 publications)
  • The British Journal of Psychiatry (2 publications)
  • The Journal of Clinical Psychiatry (2 publications)
  • Personalized Medicine in Psychiatry (1 publication)
  • Psycho-Oncology (1 publication)

Their research contributions also cover a variety of subfields, including general health professions, pharmacology, psychiatry and mental health, philosophy, and biological psychiatry.

Best Publications

  • Acute and Longer- Term Outcomes in Depressed Outpatients Requiring One or Several Treatment Steps: A STAR*D Report

    A. John Rush;Madhukar H. Trivedi;Stephen R. Wisniewski;Andrew A. Nierenberg

  • Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice

    Madhukar H. Trivedi;A. John Rush;Stephen R. Wisniewski;Andrew A. Nierenberg

  • Bupropion-SR, sertraline, or venlafaxine-XR after failure of SSRIs for depression.

    A. John Rush;Madhukar H. Trivedi;Stephen R. Wisniewski;Jonathan W. Stewart

  • Medication Augmentation after the Failure of Ssris for Depression

    Madhukar H Trivedi;Maurizio Fava;Stephen R. Wisniewski;Michael E. Thase

  • Effectiveness of Adjunctive Antidepressant Treatment for Bipolar Depression

    Gary S. Sachs;Andrew A. Nierenberg;Joseph R. Calabrese;Lauren B. Marangell

  • Sequenced treatment alternatives to relieve depression (STAR * D): rationale and design

    A.John Rush;Maurizio Fava;Stephen R Wisniewski;Philip W Lavori

  • Long-term implications of early onset in bipolar disorder: Data from the first 1000 participants in the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD)

    Roy H Perlis;Sachiko Miyahara;Lauren B Marangell;Stephen R Wisniewski

  • Predictors of recurrence in bipolar disorder: primary outcomes from the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD).

    Roy H. Perlis;Michael J. Ostacher;Jayendra K. Patel;Lauren B. Marangell

  • The International Society for bipolar Disorders (ISBD) task force report on antidepressant use in bipolar disorders

    Isabella Pacchiarotti;David J. Bond;Ross J. Baldessarini;Willem A. Nolen

  • Anxiety disorder comorbidity in bipolar disorder patients: data from the first 500 participants in the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD).

    Naomi M Simon;Michael W Otto;Stephen R Wisniewski;Mark Fossey

  • Vagus nerve stimulation for treatment-resistant depression: a randomized, controlled acute phase trial.

    A. John Rush;Lauren B. Marangell;Harold A. Sackeim;Mark S. George;Mark S. George

  • Psychosocial treatments for bipolar depression: a 1-year randomized trial from the Systematic Treatment Enhancement Program

    David J. Miklowitz;Michael W. Otto;Ellen Frank;Noreen A. Reilly-Harrington

  • Effect of Age at Onset on the Course of Major Depressive Disorder

    Sidney Zisook;Ira Lesser;Jonathan W. Stewart;Stephen R. Wisniewski

  • Background and rationale for the sequenced treatment alternatives to relieve depression (STAR*D) study.

    Maurizio Fava;A. John Rush;Madhukar H. Trivedi;Andrew A. Nierenberg

  • Rationale, design, and methods of the systematic treatment enhancement program for bipolar disorder (STEP-BD)

    Gary S Sachs;Michael E Thase;Michael W Otto;Mark Bauer

  • Telomere shortening and mood disorders: preliminary support for a chronic stress model of accelerated aging.

    Naomi M. Simon;Jordan W. Smoller;Kate L. McNamara;Richard S. Maser

  • Residual symptoms in depressed patients who respond acutely to fluoxetine.

    Andrew A. Nierenberg;Bronwyn R. Keefe;Vinita C. Leslie;Jonathan E. Alpert

  • A Comparison of Lithium and T 3 Augmentation Following Two Failed Medication Treatments for Depression: A STAR*D Report

    Andrew A. Nierenberg;Maurizio Fava;Madhukar H. Trivedi;Stephen R. Wisniewski

  • An Evaluation of the Quick Inventory of Depressive Symptomatology and the Hamilton Rating Scale for Depression: A Sequenced Treatment Alternatives to Relieve Depression Trial Report

    A. John Rush;Ira H. Bernstein;Madhukar H. Trivedi;Thomas J. Carmody

  • Residual symptoms after remission of major depressive disorder with citalopram and risk of relapse: a STAR*D report.

    A. A. Nierenberg;Mustafa Husain;Madhukar H Trivedi;M. Fava

Frequent Co-Authors

Maurizio Fava
Maurizio Fava Harvard University
Louisa G. Sylvia
Louisa G. Sylvia Harvard University
Jonathan E. Alpert
Jonathan E. Alpert Harvard University
Michael E. Thase
Michael E. Thase University of Pennsylvania
Thilo Deckersbach
Thilo Deckersbach Harvard University
Jerrold F. Rosenbaum
Jerrold F. Rosenbaum Harvard University
Madhukar H. Trivedi
Madhukar H. Trivedi The University of Texas Southwestern Medical Center
Stephen R. Wisniewski
Stephen R. Wisniewski University of Pittsburgh
Gary S. Sachs
Gary S. Sachs Harvard University
Terence A. Ketter
Terence A. Ketter Stanford University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring online healthcare degrees can expand your career options beyond traditional medical school. For those interested in nutrition and wellness, a nutrition bachelor degree online offers a flexible way to enter dietetics or community health roles.

Advancement into healthcare management is possible with the best mha programs available online. These degrees prepare graduates for leadership positions in hospitals and healthcare systems.

Registered nurses looking to boost credentials can benefit from an rn to bsn online no clinicals accredited option, designed especially for working professionals needing maximum flexibility.

For nurses seeking the highest level of clinical practice, consider the shortest dnp program online. These enable rapid advancement into top nursing and leadership roles.

By exploring these varied online degrees, you can tailor your career pathway to match your goals, interests, and lifestyle, all while furthering your impact in the healthcare field.

Best Scientists Citing Andrew A. Nierenberg

Trending Scientists